Hindustan Times (Lucknow)

MAHA COMPANY TO PRODUCE 228 MN COVAXIN DOSES ANNUALLY

- Rhythma Kaul letters@hindustant­imes.com

NEW DELHI : The Centre on Wednesday said that the Maharashtr­a-owned Haffkine Biopharmac­eutical Corp will produce 228 million Covaxin doses per annum as part of a technology transfer arrangemen­t with vaccine maker Bharat Biotech , a move that will increase the number of Covid-19 vaccines produced locally.

The announceme­nt came days after the Centre last week rejected criticism from several states that it was not doing enough to improve vaccine production in the country and said, Haffkine , the national Dairy developmen­t Board promoted Indian Immunulogi­cals and the Centre-owned Bharat Immunologi­cals and Biological­s will together aim to produce up to 40 million doses of Covid-19 vaccines by December. It said this was apart from Bharat Biotech’s own efforts to enhance Covaxin production to 100 million doses per month by October.

Newspapers in English

Newspapers from India